MedTrace Logo

Addressing School-related Gender-based Violence as Part of the Keeping Girls in School Initiative in Zambia

NCT05839457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6000

Last updated 2024-07-24

No results posted yet for this study

Summary

The objective of this mixed-methods study is to evaluate the effectiveness of a school-based safe-space program delivered to secondary school students in Zambia. The quantitative component of the study uses a randomized controlled trial to measure changes in students' experience of school-related gender-based violence (SRGBV), attitudes towards gender and SRGBV, socio-emotional well-being, and school climate, among other outcomes. Meanwhile, the qualitative component of the study aims to understand the prevailing norms around SRGBV in schools, the perception of the intervention and its impact, and the potential mechanisms through which the intervention generates its outcomes.

Conditions

  • Gender-based Violence

Interventions

BEHAVIORAL

Empowerment Pilot

The Empowerment Pilot is a school-based program aimed to raise awareness and change attitudes around SRGBV among students and teachers and promote gender equality. This intervention includes training provided by Teacher Mentors to other teachers in school, learning sessions delivered via safe spaces for student learners, and guidance for engaging parent-teacher committees.

Sponsors & Collaborators

  • World Bank

    lead OTHER

Principal Investigators

  • Wei Chang · World Bank

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-08
Primary Completion
2024-04-07
Completion
2024-04-07

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05839457 on ClinicalTrials.gov